Blank Cover Image

Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: The JAPAN-ACS subanalysis study

フォーマット:
論文
責任表示:
Takashima, Hiroaki ; Ozaki, Yukio ; Morimoto, Takeshi ; Kimura, Takeshi ; Hiro, Takafumi ; Miyauchi, Katsumi ; Nakagawa, Yoshihisa ; Yamagishi, Masakazu ; Daida, Hiroyuki ; Mizuno, Tomofumi ; Asai, Kenji ; Kuroda, Yasuo ; Kosaka, Takashi ; Kuhara, Yasushi ; Kurita, Akiyoshi ; Maeda, Kazuyuki ; Amano, Tetsuya ; Matsuzaki, Masunori ; 山岸, 正和
言語:
英語
出版情報:
Japanese Circulation Society = 日本循環器学会, 2012
著者名:
Takashima, Hiroaki
Ozaki, Yukio
Morimoto, Takeshi
Kimura, Takeshi
Hiro, Takafumi
Miyauchi, Katsumi
Nakagawa, Yoshihisa
Yamagishi, Masakazu
Daida, Hiroyuki
Mizuno, Tomofumi
Asai, Kenji
Kuroda, Yasuo
Kosaka, Takashi
Kuhara, Yasushi
Kurita, Akiyoshi
Maeda, Kazuyuki
Amano, Tetsuya
Matsuzaki, Masunori
山岸, 正和
続きを見る
掲載情報:
Circulation Journal
ISSN:
1346-9843  CiNii Research  Webcat Plus  JAIRO
巻:
76
通号:
12
開始ページ:
2840
終了ページ:
2847
バージョン:
publisher
概要:
金沢大学医薬保健研究域医学系<br />Background: The JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome) trial showed that intensive statin therapy could induce significant coronary plaque regression in acute coron ary syndrome (ACS). We evaluated the impact of metabolic syndrome (MetS) and its components on coronary plaque regression in the JAPAN-ACS patients. Methods and Results: Serial intravascular ultrasound measurements over 8-12 months were performed in 242 ACS patients receiving pitavastatin or atorvastatin. Patients were divided into groups according to the presence of MetS or the number of MetS components. Although the percent change in plaque volume (%PV) was not significantly different between the MetS (n=119) and non-MetS (n=123) groups (P=0.50), it was significantly associated with an increasing number of MetS components (component 0: -24.0%, n=7; components 1: -20.8%, n=31; components 2: -16.1%, n=69; components 3: -18.7%, n=83; components 4: -13.5%, n=52; P=0.037 for trend). The percent change in body mass index (%BMI) significantly correlated with %PV (r=0.15, P=0.021), especially in the MetS components 4 group (r=0.35, P=0.017). In addition, %BMI was an independent predictor of plaque regression after adjustment for the changes of low- and high-density lipoprotein cholesterol, triglycerides and HbA1c. Conclusions: The clustering of MetS components, but not the presence of MetS itself, could attenuate coronary plaque regression during intensive statin therapy in ACS patients. Therefore, to achieve a greater degree of plaque regression, it is necessary to treat to each MetS component and use lifestyle modification.<br />出版者照会後に全文公開 続きを見る
URL:
http://hdl.handle.net/2297/00050642
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Hiro, Takafumi, Kimura, Takeshi, Morimoto, Takeshi, Miyauchi, Katsumi, Nakagawa, Yoshihisa, Yamagishi, Masakazu, Ozaki, &hellip;

Japanese Circulation Society = 日本循環器学会

Miyauchi, Katsumi, Daida, Hiroyuki, Morimoto, Takeshi, Hiro, Takafumi, Kimura, Takeshi, Nakagawa, Yoshihisa, Yamagishi, &hellip;

Japanese Circulation Society = 日本循環器学会

Fukushima, Yoshifumi, Daida, Hiroyuki, Morimoto, Takeshi, Kasai, Takatoshi, Miyauchi, Katsumi, Yamagishi, Sho-ichi, &hellip;

BioMed Central

Naito, Ryo, Miyauchi, Katsumi, Daida, Hiroyuki, Morimoto, Takeshi, Hiro, Takafumi, Kimura, Takeshi, Nakagawa, Yoshihisa, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Fukushima, Yoshifumi, Daida, Hiroyuki, Morimoto, Takeshi, Kasai, Takatoshi, Miyauchi, Katsumi, Yamagishi, Sho-ichi, &hellip;

BioMed Central Ltd.

Takayama, Tadateru, Hiro, Takafumi, Yamagishi, Masakazu, Daida, Hiroyuki, Saito, Satoshi, Yamaguchi, Tetsu, Matsuzaki, &hellip;

Japanese Circulation Society = 日本循環器学会

Miyauchi, Katsumi, Kimura, Takeshi, Morimoto, Takeshi, Nakaagawa, Yoshihisa, Yamagishi, Masakazu, Ozaki, Yukio, Hiro, &hellip;

Japanese Circulation Society = 日本循環器学会

Daida, Hiroyuki, Takayama, Tadateru, Hiro, Takafumi, Yamagishi, Masakazu, Hirayama, Atsushi, Saito, Satoshi, Yamaguchi, &hellip;

BioMed Central

Miyauchi, Katsumi, Kimura, Takeshi, Morimoto, Takeshi, Nakagawa, Yoshihisa, Yamagishi, Masakazu, Ozaki, Yukio, Hiro, &hellip;

Japanese Circulation Society = 日本循環器学会

Arai, Hidenori, Hiro, Takafumi, Kimura, Takeshi, Morimoto, Takeshi, Miyauchi, Katsumi, Nakagawa, Yoshihisa, Yamagishi, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Nakahashi, Takuya, Tada, Hayato, Sakata, Kenji, Nomura, Akihiro, Ohira, Miho, Mori, Mika, Takamura, Masayuki, Hayashi, &hellip;

日本動脈硬化学会 = Japan Atherosclerosis Society